Circulating miR-21, miR-29a, and miR-126 are associated with premature death risk due to cancer and cardiovascular disease: the JACC Study
Open Access
- 5 March 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Scientific Reports
- Vol. 11 (1), 1-9
- https://doi.org/10.1038/s41598-021-84707-7
Abstract
Primary prevention of premature death is a public health concern worldwide. Circulating microRNAs (miRNAs) have been described as potential diagnostic biomarkers for diseases as cancer and cardiovascular disease (CVD). This case-cohort study aimed to investigate the potential relationship between circulating miRNAs and the risk of premature death. A total of 39,242 subjects provided baseline serum samples in 1988–1990. Of these, 345 subjects who died of intrinsic disease (< 65 years old) and for which measurable samples were available were included in this study. We randomly selected a sub-cohort of 879 subjects. Circulatring miR-21, miR-29a, and miR-126 were determined using qRT-PCR. Conditional logistic regression models were used to analyse the data with respect to stratified miRNA levels. Multivariable logistic regression revealed that subjects with high circulating miR-21 and miR-29a individual levels had a significantly higher risk of total death, cancer death, and CVD death than those with medium miR-21 and miR-29a individual levels. Conversely, subjects with low circulating miR-126 levels had a significantly higher risk of total death than those with medium levels. This suggests that circulating miRNAs are associated with the risk of premature death from cancer and CVD, identifying them as potential biomarkers for early detection of high-risk individuals.Funding Information
- JSPS KAKEN (16H06277)
This publication has 57 references indexed in Scilit:
- Associations of Circulating MicroRNAs (miR-17, miR-21, and miR-150) and Chronic Kidney Disease in a Japanese PopulationJournal of Epidemiology, 2020
- A Review of Physical Activity and Circulating miRNA Expression: Implications in Cancer Risk and ProgressionCancer Epidemiology, Biomarkers & Prevention, 2018
- Socioeconomic status and the 25 × 25 risk factors as determinants of premature mortality: a multicohort study and meta-analysis of 1·7 million men and womenThe Lancet, 2017
- Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate dataThe Lancet, 2017
- Modifiable causes of premature death in middle-age in Western Europe: results from the EPIC cohort studyBMC Medicine, 2016
- Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USAThe Lancet, 2014
- Trends in inequalities in premature mortality: a study of 3.2 million deaths in 13 European countriesJournal of Epidemiology and Community Health, 2014
- Alcohol and mortality in Russia: prospective observational study of 151 000 adultsThe Lancet, 2014
- Tobacco Control and the Reduction in Smoking-Related Premature Deaths in the United States, 1964-2012JAMA, 2014
- Circulating MicroRNAsCirculation Research, 2012